Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Toronto - Free Realtime Quote CAD

Appili Therapeutics Inc. (APLI.TO)

0.0300
-0.0050
(-14.29%)
As of 10:15:08 AM EDT. Market Open.
Advanced Chart
Loading Chart for APLI.TO
  • Previous Close 0.0350
  • Open 0.0300
  • Bid 0.0300 x --
  • Ask 0.0350 x --
  • Day's Range 0.0300 - 0.0300
  • 52 Week Range 0.0250 - 0.0500
  • Volume 1,428
  • Avg. Volume 57,442
  • Market Cap (intraday) 3.638M
  • Beta (5Y Monthly) -0.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date Jun 23, 2025 - Jun 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin in Phase III clinical trials for the treatment of cutaneous leishmaniasis and disfiguring skin infections; and ATI-1701, which is a live-attenuated vaccine in preclinical trials for Francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.

appilitherapeutics.com

--

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Appili Therapeutics Inc.

Recent News: APLI.TO

View More
View More

Performance Overview: APLI.TO

Trailing total returns as of 5/5/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

APLI.TO
14.29%
S&P/TSX Composite index (^GSPTSE)
1.54%

1-Year Return

APLI.TO
14.29%
S&P/TSX Composite index (^GSPTSE)
13.90%

3-Year Return

APLI.TO
71.43%
S&P/TSX Composite index (^GSPTSE)
20.79%

5-Year Return

APLI.TO
98.00%
S&P/TSX Composite index (^GSPTSE)
68.78%

Compare To: APLI.TO

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

APLI.TO
Appili Therapeutics Inc.
0.0300
-14.29%
Mkt Cap CAD 3.638M
Industry Biotechnology
MBIO.CN
MindBio Therapeutics Corp.
0.0100
0.00%
Mkt Cap CAD 1.43M
Industry Biotechnology
BETR.CN
BetterLife Pharma Inc.
0.0900
0.00%
Mkt Cap CAD 11.719M
Industry Biotechnology
MSCL.TO
Satellos Bioscience Inc.
0.6700
+1.52%
Mkt Cap CAD 111.099M
Industry Biotechnology
AVBP
ArriVent BioPharma, Inc.
21.01
-1.39%
Mkt Cap 715.119M
Industry Biotechnology
MBX.TO
Microbix Biosystems Inc.
0.3950
+1.28%
Mkt Cap CAD 55.946M
Industry Biotechnology
MDNA.TO
Medicenna Therapeutics Corp.
1.0900
+3.81%
Mkt Cap CAD 85.255M
Industry Biotechnology
SNSE
Sensei Biotherapeutics, Inc.
0.4288
+2.51%
Mkt Cap 10.809M
Industry Biotechnology
KAPA
Kairos Pharma, Ltd.
0.8500
+4.51%
Mkt Cap 14.189M
Industry Biotechnology
ADTX
Aditxt, Inc.
2.3000
+3.14%
Mkt Cap 2.778M
Industry Biotechnology
XCUR
Exicure, Inc.
10.73
+0.19%
Mkt Cap 67.79M
Industry Biotechnology

Statistics: APLI.TO

View More

Valuation Measures

As of 5/2/2025

  • Market Cap

    4.24M

  • Enterprise Value

    15.34M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    34.02

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    122.99

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -306.73%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    124.75k

  • Net Income Avi to Common (ttm)

    -3.96M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    186.17k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -7.67M

View More

Research Analysis: APLI.TO

View More
View More

People Also Watch

MDNA.TO Medicenna Therapeutics Corp.
1.0900
+3.81%
 
APS.TO Aptose Biosciences Inc.
2.8000
0.00%
 
CRDL.TO Cardiol Therapeutics Inc.
1.5600
-1.27%
 
MBX.TO Microbix Biosystems Inc.
0.3950
+1.28%
 
AVCN.TO Avicanna Inc.
0.2500
+6.38%
 
EDT.TO Spectral Medical Inc.
0.8300
0.00%
 
WLLW.TO Willow Biosciences Inc.
0.0100
0.00%
 
DYA.TO dynaCERT Inc.
0.1550
-3.12%
 
CRRX.TO CareRx Corporation
2.7200
-1.45%
 
HBP.TO Helix BioPharma Corp.
0.9600
0.00%
 
CPH.TO Cipher Pharmaceuticals Inc.
14.24
-2.20%
 
PRN.TO Profound Medical Corp.
7.55
+2.86%
 
NEWU.V Newtopia Inc.
0.0050
0.00%
 
PEA.TO Pieridae Energy Limited
0.3200
0.00%
 
VQS.TO VIQ Solutions Inc.
0.1800
+5.88%
 
HLS.TO HLS Therapeutics Inc.
4.3300
-1.59%